30 Day Trial

Vericel Reports 3Q18 MACI Revenue of $16.4MM, +65.7% vs. 3Q17


Vericel posts another record quarter for MACI with revenue of US $16.4MM, +65.7% vs. 3Q17.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.